Sakurasaku Plus Co (TSE:7097) EBIT: 円1,054 Mil (TTM As of Jan. 2026)


TSE:7097 Sakurasaku Plus Co Ltd TSE:7097
65 GF Score
Price 円3,000.00
GF Value 円1,459.55
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Sakurasaku Plus Co EBIT?

Sakurasaku Plus Co TSE:7097 -0.33% 65 EBIT is 円1,054 Mil as of Jan. 2026. GuruFocus rates TSE:7097 with a GF Score™ of 65/100 and a GF Value™ of 円1,459.55 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Sakurasaku Plus Co's earnings before interest and taxes (EBIT) for the six months ended in Jan. 2026 was 円460 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2026 was 円1,054 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sakurasaku Plus Co's annualized ROC % for the quarter that ended in Jan. 2026 was 5.29%. Sakurasaku Plus Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was 11.11%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sakurasaku Plus Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was 6.70%.

Sakurasaku Plus Co  (TSE:7097) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sakurasaku Plus Co's annualized ROC % for the quarter that ended in Jan. 2026 is calculated as:

ROC % (Q: Jan. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jul. 2025 ) + Invested Capital (Q: Jan. 2026 ))/ count )
=1050 * ( 1 - 40.05% )/( (10314 + 13488)/ 2 )
=629.475/11901
=5.29 %

where

Invested Capital(Q: Jul. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=13258 - 1126 - ( 2521 - max(0, 2948 - 4766+2521))
=10314

Invested Capital(Q: Jan. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=15363 - 174 - ( 2489 - max(0, 3473 - 5174+2489))
=13488

Note: The Operating Income data used here is two times the semi-annual (Jan. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Sakurasaku Plus Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2025  Q: Jan. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=920/( ( (7803 + max(-752, 0)) + (8755 + max(-942, 0)) )/ 2 )
=920/( ( 7803 + 8755 )/ 2 )
=920/8279
=11.11 %

where Working Capital is:

Working Capital(Q: Jul. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 738 + 368) - (1126 + 0 + 732)
=-752

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 648 + 432) - (174 + 0 + 1848)
=-942

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jan. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sakurasaku Plus Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2026 )
=1054/15724.548
=6.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sakurasaku Plus Co EBIT Related Terms

Sakurasaku Plus Co EBIT Historical Data

* Premium members only.

The historical data trend for Sakurasaku Plus Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sakurasaku Plus Co EBIT Chart

Sakurasaku Plus Co Annual Data
Trend Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
EBIT
Get a 7-Day Free Trial 1,680.00 873.00 432.00 524.00 750.00

Sakurasaku Plus Co Semi-Annual Data
Jul18 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 204.00 320.00 156.00 594.00 460.00

TSE:7097 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Sakurasaku Plus Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sakurasaku Plus Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sakurasaku Plus Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sakurasaku Plus Co's EV-to-EBIT falls into.


TSE:7097
65GF Score
Sakurasaku Plus Co Ltd TSE:7097
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sakurasaku Plus Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円1,054 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円1,054 Mil mean?
Sakurasaku Plus Co (TSE:7097) has a EBIT of 円1,054 Mil as of Jan. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sakurasaku Plus Co.
Is Sakurasaku Plus Co's EBIT too high?
Sakurasaku Plus Co's current EBIT is 円1,054 Mil. Overall, Sakurasaku Plus Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sakurasaku Plus Co's EBIT compare to HCA and THC?
Sakurasaku Plus Co's EBIT of 円1,054 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sakurasaku Plus Co. Sakurasaku Plus Co's current EBIT is 円1,054 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sakurasaku Plus Co stock overvalued right now?
Based on GuruFocus' analysis, Sakurasaku Plus Co (TSE:7097) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,459.55, compared to a current price of 円3,000.00 — trading 105.5% above its estimated fair value. The current EBIT is 円1,054 Mil. Sakurasaku Plus Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Sakurasaku Plus Co (TSE:7097), the current EBIT is 円1,054 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sakurasaku Plus Co (TSE:7097) Overvalued in 2026?

Based on GuruFocus' analysis, Sakurasaku Plus Co stock appears to be overvalued. The current stock price of 円3,000.00 is trading 105.5% above its estimated GF Value™ of 円1,459.55. GuruFocus considers Sakurasaku Plus Co to be Significantly Overvalued.

Key valuation signals for TSE:7097:

  • EBIT: 円1,054 Mil
  • GF Value™: 円1,459.55 vs. price of 円3,000.00 (105.5% above fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the TSE:7097 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sakurasaku Plus Co Business Description

Address 1-2-2 Yurakucho, Chiyoda-ku, Toho Hibiya Building, Tokyo, JPN, 100-0006
Sakurasaku Plus Co Ltd is engaged in the operation and use of childcare daycare centers. The company also provides real estate brokerage and management services. The Group operates in a single segment, the children and childcare support business.
65GF Score

Get the complete analysis for TSE:7097

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,000.00
Price
円1,459.55
GF Value